From March 1, China Customs will implement two new regulations

Published in:2019-03-04

500 supervision methods

 

 

 

 

 

 Announcement on Adding Customs Supervision Methods

 

 ( Announcement No. 20 of 2019 of the General Administration of Customs )

 

 

 

 In order to meet the requirements of the national customs clearance integration reform, promote enterprises to standardize declaration and standardize customs business management, the General Administration of Customs has decided to add customs supervision methods, which are hereby announced as follows:

 

 

 

 The addition of the customs supervision method " Royalty Follow - up Tax" code 9500 is applicable to taxpayers who pay royalties after the goods are imported and declare and pay taxes to the customs within the prescribed time limit after the royalties are paid.

 

 

 

 This announcement will be implemented as of March 1, 2019.

 

 It is hereby announced.

 

 General administration of customs

 

 January 23, 2019

 

 

 

 

 

 ▲ Add 9500 Schematic Diagram of Supervision Methods ( Informal Environment )

 

 

 

 Related links:

 

 9500?  Why should the customs add this new supervision method?

 

 

 

 

 

 

 

 Tax Reduction for Rare Disease Drugs

 

 

 

 Notice on Value Added Tax Policy for Rare Disease Drugs

 

 Caishui [ 2019 ] No. 24

 

 

 

 The finance departments ( bureaus ) of all provinces, autonomous regions, municipalities directly under the central government and cities specifically designated in the state plan, the finance bureau of Xinjiang production and construction corps, the Guangdong branch of the general administration of customs, the customs directly under the state administration of taxation, and the tax bureaus of all provinces, autonomous regions, municipalities directly under the central government and cities specifically designated in the state plan:

 

 

 

 In order to encourage the development of rare disease pharmaceutical industry and reduce the medication cost of patients, the VAT policy for rare disease drugs is hereby notified as follows:

 

 

 

 First, starting from March 1, 2019, the general VAT taxpayers who produce, sell, wholesale and retail rare disease drugs can choose to pay VAT according to the simple method and the 3% levy rate.  The above-mentioned taxpayers have chosen a simple method to calculate and pay value-added tax, which shall not be changed within 36 months.

 

 

 

 II. Starting from March 1, 2019, import value-added tax will be levied at a reduced rate of 3% on imported rare disease drugs.

 

 

 

 Three, taxpayers should separate accounting of rare disease drug sales.  Without separate accounting, the simple collection policy stipulated in article 1 of this notice shall not apply.

 

 

 

 Four, the " rare disease drugs" mentioned in this notice refers to the rare disease drug preparations and bulk drugs approved and registered by the state drug supervision and administration department.  The list of rare disease drugs ( the first batch ) is attached.  The scope of rare disease drugs shall be dynamically adjusted, and shall be defined by the Ministry of Finance, the General Administration of Customs, the General Administration of Taxation and the Food and Drug Administration in due course according to the changes.

 

   

 

 Annex: List of Rare Disease Drugs ( First Batch )

 

   

 

 Ministry of Finance, General Administration of Customs, State Administration of Taxation, Food and Drug Administration

 

 February 20, 2019

 

 

 

 

 

 

 

 

 

 Related links:

 

 Announcement of Tax Reduction List of First 21 Rare Diseases Drugs ( with Matters for Attention in Declaration )